Quantitation of benzodiazepines in whole blood by electron impact-gas chromatography-mass spectrometry. 2008

Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
Palm Beach County Sheriff's Office, 3228 Gun Club Road, West Palm Beach, Florida 33406, USA. TiscioneN@pbso.org

Benzodiazepines are frequently encountered in forensic toxicology. A literature search was conducted to find a simple method using electron impact-gas chromatography-mass spectrometry (EI-GC-MS) to examine whole blood specimens for the most commonly encountered benzodiazepines in the United States. A recently published method was identified in the literature search and used as a starting point for development of a new procedure to be used for routine analysis of forensic toxicology case samples. The procedure was then developed and validated as a rapid and efficient method for the screening and quantitation of benzodiazepines in blood using liquid-liquid extraction and EI-GC-MS in selective ion monitoring mode. Materials and instrumentation common to most forensic toxicology laboratories were utilized while obtaining LODs from 5 to 50 ng/mL and LOQs of 50 ng/mL or less using 1 mL of sample. Target compounds were chosen based on availability and common use in the United States and include diazepam, desalkylflurazepam, nordiazepam, midazolam, oxazepam, temazepam, lorazepam, clonazepam, and alprazolam (relative elution order). The linear range (r2 > 0.990) was validated from 50 to 1000 ng/mL for all analytes. The CV of replicate analyses at both 50 and 200 ng/mL was less than 4%. Quantitative accuracy was within +/- 16% at 50 ng/mL and within +/- 7% at 200 ng/mL. The validated method provides an efficient procedure for the quantitation of a broad range of the most common benzodiazepines in blood at meaningful limits of detection and quantitation using standard laboratory equipment and a small amount of sample.

UI MeSH Term Description Entries
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D053593 Forensic Toxicology The application of TOXICOLOGY knowledge to questions of law. Toxicology, Forensic

Related Publications

Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
July 1995, Journal of chromatography. B, Biomedical applications,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
January 2010, Methods in molecular biology (Clifton, N.J.),
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
November 1995, Biochemical Society transactions,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
January 1997, Methods in enzymology,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
March 1973, Analytical chemistry,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
September 2000, Forensic science international,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
June 1992, Biological mass spectrometry,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
May 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
September 2018, Journal of pharmaceutical and biomedical analysis,
Nicholas B Tiscione, and Xiaoqin Shan, and Ilene Alford, and Dustin Tate Yeatman
June 1991, Journal of lipid research,
Copied contents to your clipboard!